Company Filing History:
1 out of 832,912 Years Active: 2013
Title: Yuming Sun: Innovator in Anticancer Drug Development
Introduction
Yuming Sun is a prominent inventor based in Dalian, China. He has made significant contributions to the field of medicinal chemistry, particularly in the development of anticancer drugs. His innovative work focuses on cyclin-dependent protein kinases (Cdks) inhibitors, which are crucial in cancer treatment.
Latest Patents
Yuming Sun holds a patent for a series of cyclin-dependent protein kinases (Cdks) inhibitors, specifically flavonoid organic amine derivatives. The patent describes a preparation method that involves using Baicalein (or Wogonin) as a lead compound, mixing it with formaldehyde solution and organic amine compounds. The process results in a product with a content of not less than 97% by weight. This invention has shown a remarkable increase in activity, being 50 times more effective than Baicalin in inhibiting Cdks. The derivatives selectively induce apoptosis in proliferative phase cancer cells while having minimal impact on normal structures. This innovation is expected to lead to the development of highly efficient and low-toxicity anticancer and AIDS drugs.
Career Highlights
Yuming Sun's career is marked by his dedication to advancing cancer treatment through innovative drug development. His work has the potential to revolutionize the way cancer is treated, offering new hope for patients.
Collaborations
Yuming Sun has collaborated with notable colleagues, including Shixuan Zhang and Yongming Bao, to further enhance his research and development efforts.
Conclusion
Yuming Sun's contributions to the field of anticancer drug development highlight his role as a leading inventor in medicinal chemistry. His innovative approaches and successful patents pave the way for future advancements in cancer treatment.